Your Article Summary
See Latest Articles“Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain-Barre Syndrome, and the Detection of Rare Severe Adverse Events
The Journal of Infectious Diseases, 07/02/09
Evans D et al. - This case study is especially timely, given the recent spread of a novel influenza A(H1N1) virus in humans in Mexico and beyond. Following this, the authors examine available safety data from clinical trials of H5N1 vaccines and briefly discuss how vaccine safety could be monitored in a postmarketing surveillance setting.
Related Articles
Medical Schools Make Plans to Address Swine Flu
AAMC Reporter, 11/03/09
Relevance Score: 70%
Cholesterol drugs may improve flu survival
The Seattle Times, 10/30/09
Relevance Score: 66%
Initial psychological responses to Influenza A, H1N1 (Swine flu)
BMC Infectious Diseases, 10/07/09
Relevance Score: 66%
Asthma and Swine Flu: What You Need to Know
U.S. News & World Report, 10/19/09
Relevance Score: 65%
EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09
Relevance Score: 65%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Guanine Exchange Factor Vav2: A Novel Potential Target for the Development of Drugs Effective in the Prevention of Papillomavirus Infection and Disease
American Journal of Therapeutics, 12/04/09
Molecular Genomic Approaches to Infectious Diseases in Resource-Limited Settings
PLoS Medicine, 12/04/09
CDC Estimates 22 Million Americans Have Been Ill With H1N1 Influenza. People With Diabetes, Asthma Account for High Percentage of Hospitalizations
American Family Physician, 12/04/09